TP53 and breast cancer: DMBA induced breast cancer in rats declared a significant reduction in the tumor suppressor gene P53 and a significant elevation in oncogenic biomarkers of Akt, PI3K and PTEN gene expression by 2, 4.3, 5.2, and 2.3 fold changes respectively.